Lumos Diagnostics Holdings Limited (ASX:LDX)
Australia · Delayed Price · Currency is AUD 0.1150
+0.0100 (9.52%)
Jun 26, 2026, 4:13 PM AEST
ASX:LDX Market Cap
ASX:LDX has a market cap or net worth of 106.25 million as of June 26, 2026. Its market cap has increased by 357.87% in one year.
Market Cap
106.25M
Enterprise Value
111.46M
Revenue
18.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.12
Market Cap Chart
Since July 5, 2021, ASX:LDX's market cap has decreased from 196.70M to 106.25M, a decrease of -45.99%. That is a compound annual growth rate of -11.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 106.25M | -52.64% |
| Dec 31, 2025 | 224.36M | 756.38% |
| Dec 31, 2024 | 26.20M | -25.44% |
| Dec 29, 2023 | 35.13M | 248.53% |
| Dec 30, 2022 | 10.08M | -93.27% |
| Dec 31, 2021 | 149.80M | -23.85% |
| Jul 5, 2021 | 196.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EBR Systems | 236.24M |
| Aroa Biosurgery | 204.08M |
| EMVision Medical Devices | 140.83M |
| SomnoMed | 117.21M |
| Saluda Medical | 100.81M |
| Epiminder | 69.23M |
| Cleo Diagnostics | 65.01M |
| Compumedics | 47.94M |